TrialEuropean journal of clinical pharmacology2007

The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin.

Y-L He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.